WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alex NemiroffGeneral Counsel and Secretary2025-11-206,230$133.65
$832.64kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-201,047$49.50
$51.83kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-20508$83.85
$42.60kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-201,557$133.65
$208.09kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-202,680$43.37
$116.23kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-20207$44.40
$9.19kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-202,351$44.40
$104.38kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-205,250$56.94
$298.94kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-11-2011,455$191.96
$2.20MSell
Lauren MastrocolaPrincipal Accounting Officer2025-11-202,145$192.71
$413.37kSell

1 of 5

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP19.57%4,894,109$1.21BInsider
Stefan Vitorovic11.75%2,939,329$728.92MInsider
Janus Henderson Group PLC11.05%2,763,859$685.41MInstitution
Holdings A. Novo9.77%2,442,080$605.61MInsider
Adage Capital Partners GP LLC9.49%2,374,085$588.75MInstitution
Adage Capital Management LP8.24%2,060,175$510.90MInsider
Blackrock Inc7.20%1,801,080$446.65MInstitution
Perceptive Advisors LLC6.26%1,564,554$387.99MInstitution
Point72 Asset Management LP5.98%1,495,986$370.99MInstitution
Vanguard Group Inc5.07%1,267,286$314.27MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX63.75%36.25%Net SellingNet Selling
PTCT85.26%14.74%Net SellingNet Selling
PCVX87.60%12.40%Net SellingNet Selling
KRYS79.21%20.79%Net SellingNet Selling
PTGX82.92%17.08%Net SellingNet Selling
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 98.64% institutional shareholders, 56.08% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 19.57% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $1.21B.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.